Anthony Faber, a professor in the Philips Institute for Oral Health Research at the Virginia Commonwealth University School of Dentistry and Massey Comprehensive Cancer Center, has received four grants totaling more than $6.3 million to aid in the development of new targeted therapies for neuroblastoma and synovial sarcoma.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe